Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy

American Journal of Medicine

Volumn 103, Issue 1, 1997, Pages 33-37

  Verrot, Denis ^a,b,e   San Marco, Marielle ^c   Dravet, Charlotte ^d   Genton, Pierre ^d   Disdier, Patrick ^a   Bolla, Gilles ^a   Harle, Jean Robert ^a   Reynaud, Laurent ^c   Weiller, Pierre Jean ^a  

^a TIMONE HOSPITAL   (France)

^b Service de médecine nucléaire HÔpital Huriez   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CENTRE SAINT PAUL   (France)

^e Centre Hospitalier des Armees Scrive   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030797383     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)90046-2     Document Type: Article

References (28)

1. Mackworth-Young C, Hugues G. Epilepsy: An early symptom of systemic lupus erythematosus J Neurol Neurosurg Psychiatry. 1985;48:185-192.
2. De Ponti F, Lechini S, Cosento M, et al. Immunological adverse effects of anticonvulsivants. What is their clinical relevance? Drug Saf. 1993;8:235-250.
3. Jain KK. Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy. Drug Exp. 1991;6:350-360.
4. Levin SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies: Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol. 1987;44:876-883.
5. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arth Rheum. 1994;37:568-571.
6. Toubi E, Kamashta MA, Panarra A, Hughes GRV. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med. 1995;99:397-401.
7. SanMarco M, Bernard D. Studies of IgG-class anticardiolipin antibodies in myasthenia gravis. Autoimmunity. 1994;18:57-63.
8. Andersen P, Mosekilde L. Immunoglobulin levels and autoantibodies in epileptics on long term anticonvulsivant therapy. Acta Med Scan. 1977;201:69-74.
9. Alarcon-Segovia D, Fishbein E, Reyes PA, Dies H, Shwadsky S. Antinuclear antibodies in patients on anticonvulsivant therapy. Clin Exp Immunol. 1972;12:39-47.
10. Grossman L, Barland P. Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients. Arth Rheum. 1981;24:927-931.
11. Meyer O, Cyna L, Haim T, Ryckewaert A. Les anticorps anti-histones de type IgG. Valeur diagnostique au cours de la polyarthrite rhumatoïde, de la sclérodermie, de la maladie lupique spontanée et médicamenteuse. Rev Rhum. 1984; 51:303-310.
12. Singsen BH, Fishman L, Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsivant. Pediatrics. 1976;57:529-534.
13. Skaer T. Medication-induced systemic lupus erythematosus. Clin Ther. 1992;14:496-506.
14. Lee SL, Chase PH. Drug-induced lupus erythematosus: A critical revue. Sem Arthr Rheum. 1975;5:83-103.
15. Rubin R. Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs. Clin Biochem. 1992;25:223-234.
16. Aarli JA. Immunological aspects of epilepsy. Brain Dev. 1993;15:41-50.
17. Asherson RA. SLE and the antiphospholipid antibody syndrome. J Rheumatol. 1993;20:1801-1802.
18. Asherson RA, Cervera R, Gharavi AE. Antiphospholipid antibodies and the antiphospholipid syndrome. Ann Med Int. 1993;144:367-376.
19. Bick RL. The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion and controversy. Am J Clin Pathol. 1993;100:477-480.
20. Love PE, Santoro SA. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders Prevalence and clinical significance. Ann Med Int. 1990;112:682-698.
21. Firer M, Sirota P, Schild K, Elizur A, Slor H. Anticardiolipin antibodies are elevated in drug-free multiply affected families with schizophrenia. J Clin Immunol. 1994;14:73-78.
22. Asherson RA, Khamashta MA, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. Am J Med. 1989;86:391-399.
23. Chancellor A, Cull R, Kilpatrick D, Warlow C. Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: Clinical and immunological features. J Neurol. 1991;238:401-407.
24. Chengappa KN, Carpenter AB, Keshavan MS, et al. Elevated IgG and IgM anticardiolipin antibodies in a subgroup of medicate and unmedicated schizophrenic patients. Biol Psychiatry. 1991;30:731-35.
25. Kajiwara K, Nagawawa H, Shimizu-Nishikawa K, et al. Molecular characterization of seizure-related genes isolated by differential screening. Biochem Biophys Res Commun. 1996;219:795-799.
26. Fitzgerald LR, Vaidya VA, Terwilliger RZ, Duman RS. Electroconvulsive seizure increases the expression of CREM (cyclic AMP response element modulator) and ICER (inducible cyclic AMP early repressor) in rat brain. J Neurochem. 1996;66:429-432.
27. Canoso RT, de Oliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis. Am J Hematol. 1988;27:272-275.
28. Rogers SW, Andrew PI, Gahring LC, et al. Antibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science. 1994;265:648-652.